Rewards and recognition Rewards and recognition There are achievements and occasions that demand recognition. We go out of way to give employees tangible rewards and more for business milestones.
Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio
Translating Human Pharma Science into Animal Health Innovation Translating Human Pharma Science into Animal Health Innovation Megan Grether shares her perspectives on the importance of translating human pharma science to accelerate innovation in animal health
BIVF funding more than doubled to 250 M€ BIVF funding more than doubled to 250 M€ Boehringer Ingelheim increases funding for its corporate venture fund, the Boehringer Ingelheim Venture Fund (BIVF), from EUR 100 to 250 million
FDA-CRL-T1D FDA-CRL-T1D US FDA issues complete response letter for treatment of adults with type 1 diabetes
Positivity... just a paw away Positivity... just a paw away Data released by Boehringer Ingelheim shows the 96% of dog owners and 91% of cat owners claim their pet has a positive impact on their daily lives.
All hands-on deck to fight the ‘zombie’ rabies virus All hands-on deck to fight the ‘zombie’ rabies virus We’re teaming up with communities and governments across Southeast Asia to fight rabies through vaccinations, education programs, and partnerships.
More Health Overview More Health Overview Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
It’s Your Heart. Protect It. The Podcast. It’s Your Heart. Protect It. The Podcast. In season 2, we hear from a range of experts to explore further how the interconnected systems call for collaboration and approach to care.
How fast can a cheetah run wild and free? How fast can a cheetah run wild and free? Cheetahs’ top speed can reach up to 120km/h. But habitat loss, illegal wildlife trade and hunting made these impressive animals critically endangered.
BI increases commitments to sustainable development BI increases commitments to sustainable development At the World Health Summit 2021, Boehringer Ingelheim announces updates to its strategic approach to sustainable development
Empowering smallholder farmers Empowering smallholder farmers The LastMile initiative improves health equity in remote areas of Africa, increasing access to animal health resources for underserved farming communities.
Award winning employer Award winning employer Boehringer Ingelheim focuses on the wellbeing of its employees – and is therefore also a "Global Top Employer 2023".
reduced-heart-failure-treatment-approval-europe reduced-heart-failure-treatment-approval-europe European approval for treatment of adults with heart failure with reduced ejection fraction
university-of-medical-excellence-harvard university-of-medical-excellence-harvard A program designed by Harvard Medical School Executive Education with the goal of accelerating clinical development and medical affairs
We’re looking for SAP developers to join our Global IT Department We’re looking for SAP developers to join our Global IT Department Are you looking to take the next step in your career? Our global IT department has new SAP developer positions available!
Interstitial lung disease in rheumatoid arthritis (RA-ILD) Interstitial lung disease in rheumatoid arthritis (RA-ILD) Interstitial lung disease (ILD) is the most common type of lung condition associated with the systemic autoimmune disease rheumatoid arthritis (RA).
Making more health through animal health Making more health through animal health Boehringer Ingelheim and Ashoka aim to build a world with a greater access to health for people, animals and their communities.
In-Reach Africa initiatives successfully completed In-Reach Africa initiatives successfully completed We are proud to report the successful completion of Kuza Afya and Tiba Yako, two of our In-Reach Africa initiatives.
Early careers Early careers At Boehringer Ingelheim, we know how important it is to lay the right foundations in your career and build on them with care and support.
S&P Animal Health Partnering Oct 2023 S&P Animal Health Partnering Oct 2023 Interview by S&P Global with Megan Grether, discussing Boehringer Ingelheim Animal Health Partnering’s ambition and approach
The status of schizophrenia care The status of schizophrenia care A closer look at the status of the schizophrenia care landscape, an often misunderstood mental health condition
Covid Global Support Programm Covid Global Support Programm COVID-19: Boehringer Ingelheim steps up effort with Global Support Program
2024 half year results innovation progress 2024 half year results innovation progress First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones
emperor-reduced-chmp-positive-opinion emperor-reduced-chmp-positive-opinion CHMP issues positive opinion for the treatment of adults with heart failure with reduced ejection fraction